When and how should nitrofurantoin be used for uncomplicated lower urinary tract infection, and what are its contraindications and alternative therapies?

Nitrofurantoin for Uncomplicated Lower Urinary Tract Infection

Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is a first-line treatment for acute uncomplicated cystitis in premenopausal, nonpregnant women with no urological abnormalities. 1

When to Use Nitrofurantoin

Nitrofurantoin is appropriate as empirical first-line therapy for uncomplicated cystitis because of:

• Minimal resistance rates among uropathogens (resistance remains low despite 60+ years of use) 1, 2
• Minimal collateral damage to gut and other microbiota due to high urinary concentration and low serum/tissue levels 1, 3
• Clinical efficacy of 88-93% and bacterial cure rates of 86-92% 1

The drug achieves these outcomes while sparing fluoroquinolones and other broad-spectrum agents for more serious infections 1, 4.

Dosing and Duration

Standard regimen: Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5 days 1, 4

Alternative formulations:

• Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5 days 5
• Nitrofurantoin macrocrystals prolonged release: 100 mg twice daily for 5 days 5

Important caveat: While some UK guidelines recommend 3-day courses, there is insufficient direct evidence supporting this shorter duration 6. The 5-day regimen has stronger evidence from randomized trials 1.

Comparative Efficacy

Nitrofurantoin performs comparably to other first-line agents:

• Versus TMP-SMX: Equivalent clinical cure rates (90% vs 90%) and bacterial cure rates (92% vs 91%) 1
• Versus fosfomycin: Superior outcomes with 70% clinical resolution versus 58% for single-dose fosfomycin (12% absolute difference, P=0.004) 7
• Versus fluoroquinolones: Similar efficacy (93% vs 95%) but fluoroquinolones should be reserved for more serious infections 1

Absolute Contraindications

Do not use nitrofurantoin in:

• Renal impairment of any degree (creatinine clearance <60 mL/min or clinically significant elevated serum creatinine) 8
• Last trimester of pregnancy (risk of hemolytic anemia in newborn) 8
• Suspected pyelonephritis or upper tract infection (inadequate tissue penetration) 1
• Known G6PD deficiency 8

Serious Adverse Effects to Monitor

Pulmonary reactions are the most concerning:

• Chronic reactions occur with continuous treatment ≥6 months, presenting insidiously with malaise, dyspnea on exertion, cough, and altered pulmonary function 8
• Acute reactions occur within the first week with fever, chills, cough, chest pain, and pulmonary infiltrates—these resolve dramatically with cessation 8
• Risk increases if chronic reactions are not recognized early; permanent pulmonary impairment can occur 8

Peripheral neuropathy may become severe or irreversible, with fatalities reported. Risk factors include renal impairment, anemia, diabetes, electrolyte imbalance, and vitamin B deficiency 8.

Hepatic reactions including hepatitis, cholestatic jaundice, and hepatic necrosis occur rarely 8.

Common but minor side effects include nausea and headache (28-34% of patients) 1.

Special Populations

Men with uncomplicated UTI: Use nitrofurantoin with caution. Approximately 27% of men may be undertreated due to insufficient tissue penetration if unrecognized prostatic involvement exists 9. Consider 7-day course if used 5. TMP-SMX may be preferable for men when local resistance is <20% 5.

VRE infections: Nitrofurantoin 100 mg orally every 6 hours is recommended for uncomplicated UTI due to vancomycin-resistant enterococcus 10.

Elderly patients: Exercise particular caution due to higher risk of renal impairment and peripheral neuropathy 8.

Alternative First-Line Agents

When nitrofurantoin cannot be used:

1. TMP-SMX 160/800 mg twice daily for 3 days if local resistance <20% 1
2. Fosfomycin 3 g single dose (inferior efficacy but acceptable alternative) 1
3. Pivmecillinam 400 mg twice daily for 3-7 days where available (Europe) 1

Reserve fluoroquinolones (ciprofloxacin, levofloxacin) for complicated infections or pyelonephritis due to collateral damage concerns 1.

Avoid β-lactams as first-line due to inferior efficacy and higher adverse effect rates; use only when other agents cannot be used 1.

Never use amoxicillin or ampicillin empirically due to very high worldwide resistance rates 1.

Key Clinical Pitfalls

• Do not use for pyelonephritis: Nitrofurantoin achieves inadequate tissue concentrations for upper tract infections 1
• Check renal function: Any degree of renal impairment is a contraindication 8
• Avoid prolonged courses: Risk of chronic pulmonary reactions increases significantly after 6 months 8
• Do not obtain routine post-treatment cultures in asymptomatic patients 5
• Culture before retreatment: If symptoms persist or recur within 2-4 weeks, obtain culture and use a different agent 5